Tweet
<img alt="" height="1" width="1" />
Delcath cancer drug delivery system aids survival
Reuters
CHICAGO (Reuters) - A drug delivery system developed by Delcath Systems Inc helped melanoma patients whose cancer had spread to their liver live more than three times as long as patients treated with best available care. The company, which announced in ...
Percutaneous Hepatic Perfusion in Patients With Hepatic MetastasesMedscape
Combination treatment ineffective for advanced melanoma patientsDaily News & Analysis
Delcath Liver Tumor System Data ImproveTheStreet.com
HemOncToday -PR Newswire (press release) -CisionWire (press release)
all 47 news articles »
More...